Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TUBB4A | P04350 | 8/20 | 1.00 |
| ▸ | TUBB | P07437 | 8/20 | 1.00 |
| ▸ | TUBA3C | P0DPH7 | 8/20 | 1.00 |
| ▸ | TUBA1B | P68363 | 8/20 | 1.00 |
| ▸ | TUBA4A | P68366 | 8/20 | 1.00 |
| ▸ | TUBB4B | P68371 | 8/20 | 1.00 |
| ▸ | TUBB3 | Q13509 | 8/20 | 1.00 |
| ▸ | TUBB2A | Q13885 | 8/20 | 1.00 |
| ▸ | TUBB8 | Q3ZCM7 | 8/20 | 1.00 |
| ▸ | TUBA3E | Q6PEY2 | 8/20 | 1.00 |
| ▸ | TUBA1A | Q71U36 | 8/20 | 1.00 |
| ▸ | TUBA1C | Q9BQE3 | 8/20 | 1.00 |
| ▸ | TUBB6 | Q9BUF5 | 8/20 | 1.00 |
| ▸ | TUBB2B | Q9BVA1 | 8/20 | 1.00 |
| ▸ | TUBB1 | Q9H4B7 | 8/20 | 1.00 |
| ▸ | NR0B1 | P51843 | 1/20 | 1.00 |
| ▸ | XDH | P47989 | 2/20 | 0.82 |
| ▸ | MAPT | P10636 | 2/20 | 0.78 |
| ▸ | MEN1 | O00255 | 1/20 | 0.78 |
| ▸ | POLB | P06746 | 1/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Casticin SCHEMBL382354 | 0.93 | TUBB4A (0.86) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| Casticin SCHEMBL29926095 | 0.93 | TUBB4A (0.86) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL31142481 | 0.93 | TUBB4A (0.86) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL31589078 | 0.93 | TUBB4A (1.00) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL31589366 | 0.93 | TUBB4A (1.00) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| Casticin SCHEMBL30442880 | 0.93 | TUBB4A (0.86) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL13560795 | 0.90 | TUBB4A (0.86) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL29649084 | 0.90 | TUBB4A (0.86) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| Axillarin SCHEMBL29929599 | 0.90 | XDH (1.00) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| Axillarin SCHEMBL29929648 | 0.90 | XDH (1.00) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2431 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12569545-B2 | Method for treating and/or improving inflammatory intestinal disease | TUNGHAI UNIVERSITY (TW) | 2026-03-10 | — | — | US | claimed |
| US-20250313900-A1 | COMPOSITIONS AND THERAPEUTIC AGENTS FOR MODULATING INFLAMMATORY RESPONSES ON BOTH TUMOR AND IMMUNE CELLS | THE METHODIST HOSPITAL | 2025-10-09 | — | — | US | claimed |
| WO-2023240291-A2 | COMPOSITIONS AND THERAPEUTIC AGENTS FOR MODULATING INFLAMMATORY RESPONSES ON BOTH TUMOR AND IMMUNE CELLS | THE METHODIST HOSPITAL SYSTEM (US) | 2023-12-14 | — | — | WO | claimed |
| US-10952458-B2 | Stevia extract containing selected steviol glycosides as flavor, salty and sweetness profile modifier | PURECIRCLE USA INC (US) | 2021-03-23 | — | — | US | claimed |
| WO-2020136240-A1 | POLYPHENOL-PEPTIDE CONJUGATES FOR NUCLEAR-TARGETED DELIVERY | Universität Wien (AT) | 2020-07-02 | — | — | WO | claimed |
| EP-3673920-A1 | POLYPHENOL-PEPTIDE CONJUGATES FOR NUCLEAR-TARGETED DELIVERY | Universität Wien (AT) | 2020-07-01 | — | — | EP | claimed |
| US-10570103-B2 | Heterocyclic compounds useful in the treatment of disease | EPIGEN BIOSCIENCES, INC. (US) | 2020-02-25 | — | — | US | claimed |
| US-10383841-B2 | Antimicrobial and antiinflammatory composition | DENOVASTELLA AB (SE) | 2019-08-20 | — | — | US | claimed |
| US-20190135767-A1 | Heterocyclic Compounds Useful In The Treatment Of Disease | EPIGEN BIOSCIENCES, INC. (US) | 2019-05-09 | — | — | US | claimed |
| US-20190076346-A1 | COMPOSITIONS THAT BRIGHTEN SKIN, PROVIDE SUN PROTECTION, AND PERMIT VITAMIN D PRODUCTION | ARMSTRONG ERNEST T (US) | 2019-03-14 | — | — | US | claimed |
| US-20070105947-A1 | External preparation for skin | KURARAY CO., LTD. (JP) | 2007-05-10 | — | — | US | claimed |
| WO-2007004952-A1 | ANTIMICROBIAL AND ANTIINFLAMMATORY COMPOSITION | DENOVASTELLA AB (SE) | 2007-01-11 | — | — | WO | claimed |
| WO-2006116815-A1 | COMPOSITION FOR THE CONTROL OF CHOLESTEROL LEVELS | VANADIS BIOSCIENCE LTD (NZ) | 2006-11-09 | — | — | WO | claimed |
| WO-2006116814-A1 | COMPOSITION AND USES THEREOF | VANADIS BIOSCIENCE LTD (NZ) | 2006-11-09 | — | — | WO | claimed |
| US-20060147398-A1 | Dendrite Elongation Inhibitor for Melanocyte and Skin Preparation for External Use Containing the Same | POLA CHEMICAL INDUSTRIES INC. (JP) | 2006-07-06 | — | — | US | claimed |
| US-20060142393-A1 | Bis(thio-hydrazide amides) for treatment of hyperplasia | SYNTA PHARMACEUTICALS CORP. | 2006-06-29 | — | — | US | claimed |
| WO-2006033913-A2 | BIS (THIO-HYDRAZIDE AMIDES) FOR TREAMENT OF HYPERPLASIA | SYNTA PHARMACEUTICALS CORP. (US) | 2006-03-30 | — | — | WO | claimed |
| CN-1720020-A | Dendrite elongation inhibitor for melanocyte and skin external preparation containing the same | POLA CHEM IND INC (JP) | 2006-01-11 | — | — | CN | claimed |
| EP-1570838-A1 | DENDRITE ELONGATION INHIBITOR FOR MELANOCYTE AND SKIN PREPARATION FOR EXTERNAL USE CONTAINING THE SAME | POLA CHEMICAL INDUSTRIES, INC. (JP) | 2005-09-07 | — | — | EP | claimed |
| EP-1543825-A1 | Skin lightening preparation comprising n-butyl resorcinol and a flavonoid | Kuraray Co., Ltd. (JP) | 2005-06-22 | — | — | EP | claimed |